During the past decade, Albuquerque Center for Rheumatology conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albuquerque Center for Rheumatology" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albuquerque Center for Rheumatology" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Albuquerque Center for Rheumatology" are "Rheumatoid Arthritis" (11 trials), "Arthritis, Rheumatoid" (4 trials), "Systemic Lupus Erythematosus" (2 trials), "Active Cutaneous Lupus Erythematosus" (1 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Albuquerque Center for Rheumatology" in a lesser frequency.

Most popular intervention types in "Albuquerque Center for Rheumatology" are "Drug" (23 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Methotrexate" (6 trials), "BI 695501" (2 trials), "Baricitinib" (2 trials) and "TNF Inhibitor" (2 trials). Other intervention names were less common.

The vast majority of trials in "Albuquerque Center for Rheumatology" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Albuquerque Center for Rheumatology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Albuquerque Center for Rheumatology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Albuquerque Center for Rheumatology, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".